Recurrent Thyroid Gland Carcinoma

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00112	Bevacizumab	1	Recruiting	1
DB08875	Cabozantinib	1	Active Not Recruiting	1
DB00002	Cetuximab	1	Recruiting	1
DB08912	Dabrafenib	1	Active Not Recruiting	1
DB01259	Lapatinib	1	Active Not Recruiting	1
DB06176	Romidepsin	1	Active Not Recruiting	1
DB00877	Sirolimus	1	Recruiting	1
DB06287	Temsirolimus	1	Recruiting	1
DB00313	Valproic acid	1	Recruiting	1
DB04849	Cediranib	1 / 2	Active Not Recruiting	1
DB00480	Lenalidomide	1 / 2	Active Not Recruiting	1
DB12218	AZD-5363	2	Recruiting	1
DB08916	Afatinib	2	Recruiting	1
DB08885	Aflibercept	2	Completed	1
DB11967	Binimetinib	2	Recruiting	1
DB08875	Cabozantinib	2	Active Not Recruiting	1
DB12483	Copanlisib	2	Recruiting	1
DB08865	Crizotinib	2	Recruiting	1
DB08912	Dabrafenib	2	Recruiting	1
DB01254	Dasatinib	2	Recruiting	1
DB12282	Defactinib	2	Recruiting	1
DB12147	Erdafitinib	2	Recruiting	1
DB09502	Fludeoxyglucose (18F)	2	Completed	1
DB11795	GSK-2636771	2	Recruiting	1
DB09293	Iodide I-131	2	Recruiting	2
DB11743	Ipatasertib	2	Recruiting	1
DB14723	Larotrectinib	2	Recruiting	1
DB09078	Lenvatinib	2	Recruiting	1
DB11740	MK-1775	2	Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB09330	Osimertinib	2	Recruiting	1
DB09073	Palbociclib	2	Recruiting	1
DB06589	Pazopanib	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB06366	Pertuzumab	2	Recruiting	1
DB11836	Sapanisertib	2	Recruiting	1
DB11689	Selumetinib	2	Completed	1
DB11689	Selumetinib	2	Recruiting	1
DB00398	Sorafenib	2	Active Not Recruiting	1
DB14546	Sulfate ion	2	Recruiting	1
DB01268	Sunitinib	2	Active Not Recruiting	1
DB01268	Sunitinib	2	Recruiting	1
DB12108	Taselisib	2	Recruiting	1
DB08911	Trametinib	2	Recruiting	2
DB00072	Trastuzumab	2	Recruiting	1
DB05773	Trastuzumab emtansine	2	Recruiting	1
DB00135	Tyrosine	2	Recruiting	1
DB13930	Ulixertinib	2	Recruiting	1
DB08828	Vismodegib	2	Recruiting	1